Synnovation Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Synnovation Therapeutics's estimated annual revenue is currently $7.6M per year.
- Synnovation Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Synnovation Therapeutics has 38 Employees.
- Synnovation Therapeutics grew their employee count by 81% last year.
Synnovation Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder | Reveal Email/Phone |
Synnovation Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $34M | 169 | 8% | N/A | N/A |
#2 | $8.4M | 42 | -28% | N/A | N/A |
#3 | $68.7M | 342 | 6% | N/A | N/A |
#4 | $49.4M | 246 | -10% | N/A | N/A |
#5 | $7.8M | 39 | 44% | N/A | N/A |
#6 | $148.3M | 738 | 8% | N/A | N/A |
#7 | $24.7M | 123 | 13% | N/A | N/A |
#8 | $0.8M | 8 | 14% | N/A | N/A |
#9 | $9M | 45 | 7% | N/A | N/A |
#10 | $3.8M | 19 | -50% | N/A | N/A |
What Is Synnovation Therapeutics?
Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets.\n\nWe are dedicated to the discovery and development of best-in-class therapeutics that can improve the lives of people living with cancer. Leveraging deep expertise in cancer biology and a world class medicinal chemistry team, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer care through patient-focused precision medicine.
keywords:N/AN/A
Total Funding
38
Number of Employees
$7.6M
Revenue (est)
81%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 38 | 9% | N/A |
#2 | $4.6M | 38 | 81% | $6M |
#3 | $4.6M | 38 | 19% | $10M |
#4 | $5.5M | 38 | 41% | N/A |
#5 | $7.4M | 38 | 0% | N/A |